Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval
Jan 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug ...
Read moreJan 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug ...
Read moreNEW YORK, Oct 14 (Reuters) - Gut-wrenching market volatility and attractive valuations are prompting some investors ...
Read moreOct 7 (Reuters) - The Biden administration on Friday published a sweeping set of export controls, ...
Read moreRegister now for FREE unlimited access to Reuters.comRegisterAll eyes on August CPI report on TuesdayBristol Myers ...
Read moreA Toronto Stock Exchange sign adorns a doorway at the Exchange Tower building in Toronto, Ontario, ...
Read moreFinancials lead declines, real estate gainsOracle falls after report co in talks to buy CernerFedEx up ...
Read moreDec 30 (Reuters) - Britain's FTSE 100 (.FTSE) index is seen opening flat on Thursday, with ...
Read moreTravel stocks edge higher after vaccine updateNasdaq in front; communications services lead sector gainsIndexes: Dow down ...
Read moreDec 23 (Reuters) - The U.S. on Thursday authorized Merck & Co's (MRK.N) antiviral pill for ...
Read more(Updates prices to close, adds commentary)S&P tech sector lead gains, chip stocks outperformMerck drags on Dow ...
Read more© 2022 TheDailyStock.News